Biotech

Sales & Marketing

Focussing on finding value in health sciences marketing

In this latest instalment of the pharmaphorum podcast, web editor Nicole Raleigh speaks with life sciences advisor Randall Hein, CEO of Heinsight LLC, and health sciences marketing expert K

Sales & Marketing

Scientists in the C-suite: Attracting investors takes more t...

In the ever-evolving landscape of the biotechnology sector, the ability to attract investors effectively stands as the decisive factor that separates the success of your pioneering research

News

Agomab raises $100m for Crohn’s drug, and other financings

Agomab Therapeutics has closed a $100 million third-round financing, heading a list of recent funding rounds that also features AstronauTx, MinervaX, Precede Bio and Limma

News

Aviva backs £1bn cancer hub in London

A £1 billion development aimed at creating a major centre for cancer research and treatment in South London has taken a step forwards with the selection of preferred bidde

News

BridgeBio’s $250m raise heads latest biotech financings

BridgeBio Pharma has raised $250 million from the sale of nine million shares that is earmarked for the commercial launch of its acoramidis drug for transthyretin amyloido

News

Ex-Novartis CMO John Tsai pops up at Forcefield

Novartis’ former chief medical officer John Tsai has returned to a senior position in biopharma, taking the role of chief executive of UK start-up Forcefield Therapeutics.

Focussing on finding value in health sciences marketing

Scientists in the C-suite: Attracting investors takes more t...

Agomab raises $100m for Crohn’s drug, and other financings

Aviva backs £1bn cancer hub in London

BridgeBio’s $250m raise heads latest biotech financings

Ex-Novartis CMO John Tsai pops up at Forcefield

Biogen, Denali pull Parkinson's drug after failed trial

Discover a new era of healthcare panel engagement: Grounded ...

Biotech

Editor's Picks